Patent details

Basic Information

Publication number:

EP1581246

PCT Application Number:

PCT/US/2003/040713

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP038138095

PCT Publication Number:

WO/2004/056317

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF NEPHROPATHY

French Title of Invention:

COMPOSITIONS DESTINÉES AU TRAITEMENT ET A LA PRÉVENTION DE LA NEPHROPATHIE

German Title of Invention:

ZUSAMMENSETZUNGEN ZUR BEHANDLUNG UND PREVENTION VON NEPHROPATHIE

SPC Number:

Dates

Filing date:

19/12/2003

Grant date:

16/01/2013

EP Publication Date:

16/01/2013

PCT Publication Date:

08/07/2004

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

05/10/2005

EP B1 Publication Date:

16/01/2013

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

19/12/2013

Expiration date:

19/12/2023

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

19/12/2003

 

 

Name:

Amylin Pharmaceuticals LLC

Address:

9360 Towne Centre Drive, San Diego, CA 92121, United States (US)

Name:

AstraZeneca Pharmaceuticals LP

Address:

1800 Concorde Pike, Wilmington, DE, United States (US)

Inventor

1

Name:

MISTRY Mahesh

Address:

United States (US)

2

Name:

ROMAN Richard, J.

Address:

United States (US)

3

Name:

HATHAWAY David, R.

Address:

United States (US)

4

Name:

BARON Alain, D.

Address:

United States (US)

Priority

1

Priority Number:

434888 P

Priority Date:

19/12/2002

Priority Country:

United States (US)

2

Priority Number:

740146

Priority Date:

17/12/2003

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 38/22;

Filing date	Document type	Number of pages